U.S. Tuberculosis Cases Rose to Their Highest Levels in More Than a Dozen Years
|
Meet the Future of Medicine: Match Day 2025 at NYU
|
Public Health, Environmental Experts Decry EPA Rule Rollbacks
|
First Drug Approved for Ultra-Rare Kidney Disease
|
Think Twice Before Quitting Oral Anticoagulants After Afib Ablation?
|
FDA Expands Guselkumab Approval to Crohn's Disease
|
Match Rates Hold Steady as Applicants Reach Record High
|
Texas Measles Outbreak Expected to Last for Months, Though Vaccinations Are Rising
|
Vutrisiran Snags FDA Approval for TTR Amyloidosis Cardiomyopathy
|
'Leaning In' to a Fresh Start in Residency
|
Newer Biologics Tied to Fewer Infections for Older Patients With Psoriatic Disease
|
Health Agencies Remain in the Dark About Next Round of Firings
|
Ob/Gyn as CDC Director? ACIP Meeting Back On; Calls for Dr. Oz to Pay $400K in Taxes
|
Alzheimer's May Be Delayed in Asymptomatic Patients, Small Trial Suggests
|
Will Stem Cell Clinics Flourish Under RFK Jr.?
|
'Tremendous Concern' Over Possible Plan to Close CDC's HIV Prevention Unit
|
Top Societies Decry Trump's Funding Cuts to Landmark Diabetes Study
|
Will Medicare Price Negotiations Really Cut Rheum Drug Costs?
|
Ovarian Cancer Blood Test Misses Some Black, Native American Patients
|
Preventive Care Mandate at Risk? More AI Wins in Cancer; Risky Short-Term Insurance
GET IN TOUCH